enow.com Web Search

  1. Ads

    related to: spiriva reviews for copd patients symptoms
    • Safety Profile

      See safety profile information

      from across clinical trials.

    • Efficacy

      See efficacy and clinical study

      information for SPIRIVA RESPIMAT.

Search results

  1. Results from the WOW.Com Content Network
  2. Tiotropium bromide - Wikipedia

    en.wikipedia.org/wiki/Tiotropium_bromide

    Tiotropium is used as maintenance treatment of chronic obstructive pulmonary disease (COPD). [16] [17] It may also be used as an add-on therapy in people with moderate-to-severe asthma on medium to high dose inhaled corticosteroids (ICS). [18] [19] It is not however approved for acute exacerbations of COPD or acute worsening of asthma. [10]

  3. Long-acting beta-adrenoceptor agonist - Wikipedia

    en.wikipedia.org/wiki/Long-acting_beta...

    This product was approved by the FDA in May 2013 as once-daily inhaled therapy for the treatment of chronic obstructive pulmonary disease (COPD) with umeclidinium bromide: Anoro Ellipta. Umeclidinium bromide is a long-acting muscarinic antagonist. [14]

  4. Bronchodilator - Wikipedia

    en.wikipedia.org/wiki/Bronchodilator

    Some examples of anticholinergics are tiotropium (Spiriva) and ipratropium bromide. [citation needed] Tiotropium is a long-acting, 24-hour, anticholinergic bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). Only available as an inhalant, ipratropium bromide is used in the treatment of asthma and COPD.

  5. A Guide for Living With COPD - AOL

    www.aol.com/lifestyle/guide-living-copd...

    This chronic respiratory disease most commonly affects women aged 65 and older. But there are ways to manage the symptoms and slow down its progression. A Guide for Living With COPD

  6. Beta2-adrenergic agonist - Wikipedia

    en.wikipedia.org/wiki/Beta2-adrenergic_agonist

    On 18 November 2005, the U.S. Food and Drug Administration (FDA) alerted healthcare professionals and patients that several long-acting bronchodilator medicines have been associated with possible increased risk of worsening wheezing in some people, and requested that manufacturers update warnings in their existing product labeling.

  7. 'I Was Diagnosed With AFib at 38—This Symptom Made Me ... - AOL

    www.aol.com/lifestyle/diagnosed-afib-38-symptom...

    Other risk factors for AFib include obesity, type 2 diabetes, chronic kidney disease, heart failure, coronary artery disease, COPD, sleep apnea and hyperthyroidism, none of which Kaveney had himself.

  1. Ads

    related to: spiriva reviews for copd patients symptoms